Back

Association between napping and nighttime sleep with the risk of recurrent events in patients with cardiovascular disease: pilot study of the MEDLIFE project

30 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Sleep disorders Sleep Disorders ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jesus Diaz-Gutierrez

Hospital Juan Ramon Jimenez, Huelva (Spain)

7 More presentations in this session

Presentation thumbnail
The association between cardiorespiratory fitness and obstructive sleep apnea in young and middle-aged adults: a retrospective study
Doctor N. Zheng (Fuzhou, CN)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis of clinical trials on the impact of sglt2 inhibitors on sleep-disordered breathing: a potential future treatment approach?
Assistant Professor K. Hosseini (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Sex differences in cardiovascular disease and biomarkers in obstructive sleep apnea
Doctor A. Romarheim (Bergen, NO)
Abstract Slides Video
Presentation thumbnail
Biological ageing mediates the associations between disrupted rest-activity circadian rhythms and all-cause and cardiovascular mortality in US adults: NHANES 2011-2014
Miss B. Gu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The heart of sleep: convergence of cardiac electrophysiology and sleep apnea variables in patient monitoring
Ms M. Sargeant (Greenville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Sleep disorders

The Event

Event poster

ESC Congress 2025

30 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of sleep duration with significant coronary artery disease requiring percutaneous coronary intervention
thumbnail
Congress Session
Sleep in cardiovascular disease prevention: screening and contemporary management
thumbnail
Congress Presentation
Association between habitual sleep duration and SCORE2-Diabetes in individuals with type 2 diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources